Bacterial Vaginosis


  • Wizal Putri Mellaratna )Dermatology and Venereology department, Universitas Malikussaleh/RSUD Cut Meutia, Aceh Utara
  • Della Vega Nisha Ayuna Student Of Faculty Of Medicine, Universitas Malikussaleh, Lhokseumawe



bacterial vaginosis, clue cells, whift test



Introduction: The vagina is normally inhabited by a number of organism, including Lactobacillus acidophilus, diphteroids, Candida and others. Normal vaginal flora contains aerobic and anaerobic bacteria, such as Lactobacillus species being the prominent microorganism with number more than 95% of the total bacteria present. Vaginal discharge can be classified into physiologic and pathologic discharge. Discussion: Bacterial vaginosis is a clinical syndrome caused by the alteration of Lactobacillus Sp that producing hydrogen peroxide with anaerobic bacteria that caused the disruption of the normal flora balance. Risk factors of bacterial vaginosis are sexual activity, vaginal douching, genetic, vaginal manipulation, smoking and using the intrauterine device. Diagnosis of bacterial vaginosis can be enforced by the gram staining and the calculation of Nugent score (positive diagnosis of bacterial vaginosis if nogent score 7-10). Amsel score can also be conducted if the Nugent score examination cannot be performed. Amsel score criteria consists of white homogen vaginal discharge, fishy odor (positive Whift test), pH > 4.5, and the finding of clue cell. The discovery of 3 citeria of Amsel can confirm the diagnosis of bacterial vaginosis. Treatment of bacterial vaginosis including systemic and topical therapy. Systemic antibiotic such as metronidazole and clindamycin is effective against the anaerob bacteria. Conclusion: bacterial vaginosis in an abnormal condition in the vagina caused by the overgrowth of anaerobic bacteria replacing the Lactobacillus hominis that caused the change of normal acidic pH vagina into alkaline.

Amsel criteria and Nugent score can be requested to confirm the diagnosis of bacterial vaginosis. Proper diagnosis and treatment with metronidazole and clindamycin can improve the disease. 


Prawirohardjo, S. Ilmu Kandungan. (PT. Bina Pustaka, 2014).

Yudin, M. H. & Money, D. M. Screening and Management of Bacterial Vaginosis in Pregnancy. J. Obstet. Gynaecol. Canada 39, e184–e191 (2017).

Russo, R., Karadja, E. & De Seta, F. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: A double blind, placebo controlled, randomised clinical trial. Benef. Microbes 10, 19–26 (2019).

Javed, A., Parvaiz, F. & Manzoor, S. Bacterial Vaginosis: An insight into the prevalence, alternative regimen treatments and it’s associated resistance patterns. Microb. Pathog. 127, 21–30 (2019).

Jain, J. P. et al. Factors in the HIV risk environment associated with bacterial vaginosis among HIV-negative female sex workers who inject drugs in the Mexico-United States border region. BMC Public Health 18, 1–10 (2018).

Goldsmith, L. A. et al. Fitzpatrick’s Dermatology in General Medicine. (The McGrawHill, 2019).

Greenbaum, S., Greenbaum, G., Moran-Gilad, J. & Weintruab, A. Y. Ecological dynamics of the vaginal microbiome in relation to health and disease. Am. J. Obstet.

Gynecol. 220, 324–335 (2019).

Han, C. et al. Aerobic vaginitis in late pregnancy and outcomes of pregnancy. Eur. J. Clin. Microbiol. Infect. Dis. 38, 233–239 (2019).

Muzny, C. A. & Schwebke, J. R. Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses. J. Infect. Dis. 214, S1–S5 (2016).

Verstraelen, H. & Swidsinski, A. The biofilm in bacterial vaginosis: Implications for epidemiology, diagnosis and treatment: 2018 update. Curr. Opin. Infect. Dis. 32, 38–42 (2019).

Djuanda, A., Hamzah, M. & Aisah, S. Ilmu Penyakit Kulit dan Kelamin. (Indonesia University, 2010).

Coleman, J. S. & Gaydos, C. A. Molecular diagnosis of bacterial vaginosis: An update. J. Clin. Microbiol. 56, 1–9 (2018).




How to Cite

Mellaratna, W. P., & Ayuna, D. V. N. (2022). Bacterial Vaginosis. Proceedings of Malikussaleh International Conference on Health and Disaster Medicine (MICOHEDMED), 1(1), 119–124.